National HealthCare Corporation (AMEX: NHC) Stock Competitors & Peer Comparison
See NHC's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NHC and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NHC | $212.79 | +2.49% | 3.3B | 26.46 | $7.86 | +1.26% |
| HCA | $505.17 | -0.46% | 103.4B | 17.09 | $28.96 | +0.62% |
| THC | $293.70 | +2.53% | 22.5B | 16.43 | $17.24 | N/A |
| EHC | $139.87 | -0.99% | 13.6B | 23.56 | $5.84 | +0.57% |
| FMS | $22.97 | -2.94% | 12.5B | 8.80 | $2.66 | +3.70% |
| DVA | $187.72 | -3.65% | 12B | 13.56 | $14.11 | N/A |
| ENSG | $182.30 | -0.05% | 10.6B | 26.23 | $6.90 | +0.14% |
| UHS | $198.21 | -0.19% | 10.1B | 8.67 | $22.54 | +0.41% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $49.54 | -1.31% | 7.9B | 26.23 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
NHC vs HCA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, HCA has a market cap of 103.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while HCA trades at $505.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas HCA's P/E ratio is 17.09. In terms of profitability, NHC's ROE is +0.10%, compared to HCA's ROE of -1.00%. Regarding short-term risk, NHC is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for NHC.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
NHC vs THC Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, THC has a market cap of 22.5B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while THC trades at $293.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas THC's P/E ratio is 16.43. In terms of profitability, NHC's ROE is +0.10%, compared to THC's ROE of +0.61%. Regarding short-term risk, NHC is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for NHC.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
NHC vs EHC Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, EHC has a market cap of 13.6B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while EHC trades at $139.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas EHC's P/E ratio is 23.56. In terms of profitability, NHC's ROE is +0.10%, compared to EHC's ROE of +0.25%. Regarding short-term risk, NHC is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for NHC.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
NHC vs FMS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, FMS has a market cap of 12.5B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while FMS trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas FMS's P/E ratio is 8.80. In terms of profitability, NHC's ROE is +0.10%, compared to FMS's ROE of +0.06%. Regarding short-term risk, NHC is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for NHC.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
NHC vs DVA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, DVA has a market cap of 12B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while DVA trades at $187.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas DVA's P/E ratio is 13.56. In terms of profitability, NHC's ROE is +0.10%, compared to DVA's ROE of -1.33%. Regarding short-term risk, NHC is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
NHC vs ENSG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ENSG trades at $182.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ENSG's P/E ratio is 26.23. In terms of profitability, NHC's ROE is +0.10%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, NHC is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for NHC.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
NHC vs UHS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, UHS has a market cap of 10.1B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while UHS trades at $198.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas UHS's P/E ratio is 8.67. In terms of profitability, NHC's ROE is +0.10%, compared to UHS's ROE of +0.20%. Regarding short-term risk, NHC is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for NHC.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
NHC vs OSH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas OSH's P/E ratio is -17.65. In terms of profitability, NHC's ROE is +0.10%, compared to OSH's ROE of +4.64%. Regarding short-term risk, NHC is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for NHC.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
NHC vs PACS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, PACS has a market cap of 7.9B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while PACS trades at $49.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas PACS's P/E ratio is 26.23. In terms of profitability, NHC's ROE is +0.10%, compared to PACS's ROE of +0.26%. Regarding short-term risk, NHC is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
NHC vs CHE Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CHE has a market cap of 6.9B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CHE trades at $538.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CHE's P/E ratio is 24.44. In terms of profitability, NHC's ROE is +0.10%, compared to CHE's ROE of +0.32%. Regarding short-term risk, NHC is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for NHC.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
NHC vs HIMS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, HIMS has a market cap of 5.8B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while HIMS trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas HIMS's P/E ratio is -40.62. In terms of profitability, NHC's ROE is +0.10%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, NHC is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check HIMS's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
NHC vs CON Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CON has a market cap of 5.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CON trades at $42.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CON's P/E ratio is 26.54. In terms of profitability, NHC's ROE is +0.10%, compared to CON's ROE of +0.48%. Regarding short-term risk, NHC is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CON's competition here
LHC Group, Inc. (NASDAQ: LHCG)
NHC vs LHCG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas LHCG's P/E ratio is 82.83. In terms of profitability, NHC's ROE is +0.10%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, NHC is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for NHC.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
NHC vs LFST Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, LFST has a market cap of 5.3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while LFST trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas LFST's P/E ratio is 103.71. In terms of profitability, NHC's ROE is +0.10%, compared to LFST's ROE of +0.05%. Regarding short-term risk, NHC is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for NHC.Check LFST's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
NHC vs OPCH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while OPCH trades at $31.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas OPCH's P/E ratio is 18.40. In terms of profitability, NHC's ROE is +0.10%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, NHC is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for NHC.Check OPCH's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
NHC vs ACHC Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ACHC has a market cap of 3.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ACHC trades at $38.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ACHC's P/E ratio is 18.58. In terms of profitability, NHC's ROE is +0.10%, compared to ACHC's ROE of -0.57%. Regarding short-term risk, NHC is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for NHC.Check ACHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
NHC vs AMED Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AMED's P/E ratio is 39.30. In terms of profitability, NHC's ROE is +0.10%, compared to AMED's ROE of +0.04%. Regarding short-term risk, NHC is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for NHC.Check AMED's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
NHC vs SGRY Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SGRY has a market cap of 3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SGRY trades at $26.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SGRY's P/E ratio is 59.45. In terms of profitability, NHC's ROE is +0.10%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, NHC is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for NHC.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
NHC vs AVAH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AVAH has a market cap of 2.9B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AVAH trades at $13.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AVAH's P/E ratio is 19.47. In terms of profitability, NHC's ROE is +0.10%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, NHC is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for NHC.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
NHC vs GRDN Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while GRDN trades at $45.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas GRDN's P/E ratio is 37.14. In terms of profitability, NHC's ROE is +0.10%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, NHC is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for NHC.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
NHC vs MD Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, MD has a market cap of 2.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while MD trades at $31.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas MD's P/E ratio is 13.96. In terms of profitability, NHC's ROE is +0.10%, compared to MD's ROE of +0.17%. Regarding short-term risk, NHC is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for NHC.Check MD's competition here
Ardent Health Inc. (NYSE: ARDT)
NHC vs ARDT Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ARDT has a market cap of 2.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ARDT trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ARDT's P/E ratio is 13.95. In terms of profitability, NHC's ROE is +0.10%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, NHC is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for NHC.Check ARDT's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
NHC vs ADUS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ADUS has a market cap of 2.3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ADUS trades at $124.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ADUS's P/E ratio is 18.61. In terms of profitability, NHC's ROE is +0.10%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, NHC is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check ADUS's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
NHC vs BKD Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, BKD has a market cap of 2.2B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while BKD trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas BKD's P/E ratio is -15.64. In terms of profitability, NHC's ROE is +0.10%, compared to BKD's ROE of +0.89%. Regarding short-term risk, NHC is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for NHC.Check BKD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
NHC vs SEM Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SEM's P/E ratio is 15.43. In terms of profitability, NHC's ROE is +0.10%, compared to SEM's ROE of +0.08%. Regarding short-term risk, NHC is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for NHC.Check SEM's competition here
Agilon Health, Inc. (NYSE: AGL)
NHC vs AGL Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AGL has a market cap of 1.9B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AGL trades at $113.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AGL's P/E ratio is -7.33. In terms of profitability, NHC's ROE is +0.10%, compared to AGL's ROE of -0.52%. Regarding short-term risk, NHC is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AGL's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
NHC vs AMEH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AMEH's P/E ratio is 39.25. In terms of profitability, NHC's ROE is +0.10%, compared to AMEH's ROE of +0.06%. Regarding short-term risk, NHC is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
NHC vs ASTH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ASTH has a market cap of 1.7B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ASTH trades at $33.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ASTH's P/E ratio is 41.61. In terms of profitability, NHC's ROE is +0.10%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, NHC is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for NHC.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
NHC vs HCSG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while HCSG trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas HCSG's P/E ratio is 16.30. In terms of profitability, NHC's ROE is +0.10%, compared to HCSG's ROE of +0.20%. Regarding short-term risk, NHC is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for NHC.Check HCSG's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
NHC vs SNDA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SNDA trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SNDA's P/E ratio is -5.29. In terms of profitability, NHC's ROE is +0.10%, compared to SNDA's ROE of -0.19%. Regarding short-term risk, NHC is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for NHC.Check SNDA's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
NHC vs USPH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, USPH has a market cap of 1.5B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while USPH trades at $98.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas USPH's P/E ratio is 39.17. In terms of profitability, NHC's ROE is +0.10%, compared to USPH's ROE of -0.00%. Regarding short-term risk, NHC is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for NHC.Check USPH's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
NHC vs AMN Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AMN has a market cap of 1.4B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AMN trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AMN's P/E ratio is 11.98. In terms of profitability, NHC's ROE is +0.10%, compared to AMN's ROE of +0.15%. Regarding short-term risk, NHC is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AMN's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
NHC vs PNTG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while PNTG trades at $37.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas PNTG's P/E ratio is 27.55. In terms of profitability, NHC's ROE is +0.10%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, NHC is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for NHC.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
NHC vs NUTX Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, NUTX has a market cap of 1.2B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while NUTX trades at $193.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas NUTX's P/E ratio is 7.15. In terms of profitability, NHC's ROE is +0.10%, compared to NUTX's ROE of +0.44%. Regarding short-term risk, NHC is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for NHC.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
NHC vs BKDT Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas BKDT's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to BKDT's ROE of +0.89%. Regarding short-term risk, NHC is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for NHC.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
NHC vs INNV Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while INNV trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas INNV's P/E ratio is -448.00. In terms of profitability, NHC's ROE is +0.10%, compared to INNV's ROE of +0.04%. Regarding short-term risk, NHC is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for NHC.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
NHC vs TALK Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TALK's P/E ratio is 774.34. In terms of profitability, NHC's ROE is +0.10%, compared to TALK's ROE of +0.00%. Regarding short-term risk, NHC is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for NHC.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
NHC vs EHAB Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas EHAB's P/E ratio is -197.14. In terms of profitability, NHC's ROE is +0.10%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, NHC is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for NHC.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
NHC vs GMRS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, GMRS has a market cap of 672.6M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while GMRS trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas GMRS's P/E ratio is -6.13. In terms of profitability, NHC's ROE is +0.10%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, NHC is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
NHC vs TOI Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TOI's P/E ratio is -14.25. In terms of profitability, NHC's ROE is +0.10%, compared to TOI's ROE of +1.51%. Regarding short-term risk, NHC is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for NHC.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
NHC vs SRTA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SRTA has a market cap of 491M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SRTA trades at $5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SRTA's P/E ratio is -26.16. In terms of profitability, NHC's ROE is +0.10%, compared to SRTA's ROE of -0.09%. Regarding short-term risk, NHC is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
NHC vs MCTA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas MCTA's P/E ratio is 419.36. In terms of profitability, NHC's ROE is +0.10%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, NHC is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for NHC.Check MCTA's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
NHC vs STLN Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, STLN has a market cap of 360.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while STLN trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas STLN's P/E ratio is -11.83. In terms of profitability, NHC's ROE is +0.10%, compared to STLN's ROE of +1.51%. Regarding short-term risk, NHC is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for NHC.Check STLN's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
NHC vs VMD Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, VMD has a market cap of 347.6M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while VMD trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas VMD's P/E ratio is 25.35. In terms of profitability, NHC's ROE is +0.10%, compared to VMD's ROE of +0.11%. Regarding short-term risk, NHC is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for NHC.Check VMD's competition here
Auna S.A. (NYSE: AUNA)
NHC vs AUNA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AUNA has a market cap of 346M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AUNA trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AUNA's P/E ratio is 4.21. In terms of profitability, NHC's ROE is +0.10%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, NHC is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
NHC vs CYH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CYH has a market cap of 311.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CYH trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CYH's P/E ratio is 3.03. In terms of profitability, NHC's ROE is +0.10%, compared to CYH's ROE of +0.36%. Regarding short-term risk, NHC is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CYH's competition here
Capital Senior Living Corporation (NYSE: CSU)
NHC vs CSU Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CSU's P/E ratio is 0.67. In terms of profitability, NHC's ROE is +0.10%, compared to CSU's ROE of -0.23%. Regarding short-term risk, NHC is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CSU's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
NHC vs FVE Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas FVE's P/E ratio is -5.64. In terms of profitability, NHC's ROE is +0.10%, compared to FVE's ROE of -0.15%. Regarding short-term risk, NHC is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for NHC.Check FVE's competition here
The Joint Corp. (NASDAQ: JYNT)
NHC vs JYNT Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, JYNT has a market cap of 96.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while JYNT trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas JYNT's P/E ratio is 45.60. In terms of profitability, NHC's ROE is +0.10%, compared to JYNT's ROE of +0.30%. Regarding short-term risk, NHC is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for NHC.Check JYNT's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
NHC vs KDLYW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas KDLYW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, NHC is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
NHC vs PARK Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, PARK has a market cap of 94.5M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while PARK trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas PARK's P/E ratio is 26.86. In terms of profitability, NHC's ROE is +0.10%, compared to PARK's ROE of -0.18%. Regarding short-term risk, NHC is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for NHC.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
NHC vs BTMD Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, BTMD has a market cap of 46.8M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while BTMD trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas BTMD's P/E ratio is 9.64. In terms of profitability, NHC's ROE is +0.10%, compared to BTMD's ROE of +0.03%. Regarding short-term risk, NHC is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for NHC.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
NHC vs ALR Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ALR's P/E ratio is -1.11. In terms of profitability, NHC's ROE is +0.10%, compared to ALR's ROE of -0.15%. Regarding short-term risk, NHC is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for NHC.Check ALR's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
NHC vs EUDA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, EUDA has a market cap of 40.8M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while EUDA trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas EUDA's P/E ratio is -11.69. In terms of profitability, NHC's ROE is +0.10%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, NHC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check EUDA's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
NHC vs CCEL Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CCEL has a market cap of 39.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CCEL trades at $5.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CCEL's P/E ratio is -21.50. In terms of profitability, NHC's ROE is +0.10%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, NHC is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CCEL's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
NHC vs AIRS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AIRS has a market cap of 38.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AIRS trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AIRS's P/E ratio is -17.91. In terms of profitability, NHC's ROE is +0.10%, compared to AIRS's ROE of -0.09%. Regarding short-term risk, NHC is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AIRS's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
NHC vs IMAC Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas IMAC's P/E ratio is -2.27. In terms of profitability, NHC's ROE is +0.10%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, NHC is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for NHC.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
NHC vs DCGO Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, DCGO has a market cap of 24.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while DCGO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas DCGO's P/E ratio is -0.13. In terms of profitability, NHC's ROE is +0.10%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, NHC is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for NHC.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
NHC vs CANO-WT Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, NHC is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
NHC vs AIH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AIH's P/E ratio is -2.78. In terms of profitability, NHC's ROE is +0.10%, compared to AIH's ROE of +1.16%. Regarding short-term risk, NHC is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
NHC vs PIIIW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, PIIIW has a market cap of 13.9M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas PIIIW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, NHC is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for NHC.Check PIIIW's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
NHC vs PIII Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, PIII has a market cap of 13.1M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while PIII trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas PIII's P/E ratio is -0.12. In terms of profitability, NHC's ROE is +0.10%, compared to PIII's ROE of +1.61%. Regarding short-term risk, NHC is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for NHC.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
NHC vs CANO Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CANO's P/E ratio is -0.01. In terms of profitability, NHC's ROE is +0.10%, compared to CANO's ROE of -1.49%. Regarding short-term risk, NHC is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
NHC vs FPCG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas FPCG's P/E ratio is 0.09. In terms of profitability, NHC's ROE is +0.10%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, NHC is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for NHC.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
NHC vs FTRP Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas FTRP's P/E ratio is -1.22. In terms of profitability, NHC's ROE is +0.10%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, NHC is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for NHC.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
NHC vs BMGL Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, BMGL has a market cap of 8.4M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while BMGL trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas BMGL's P/E ratio is -1.06. In terms of profitability, NHC's ROE is +0.10%, compared to BMGL's ROE of -0.11%. Regarding short-term risk, NHC is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for NHC.Check BMGL's competition here
American Shared Hospital Services (AMEX: AMS)
NHC vs AMS Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AMS has a market cap of 7.8M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AMS trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AMS's P/E ratio is -4.63. In terms of profitability, NHC's ROE is +0.10%, compared to AMS's ROE of -0.07%. Regarding short-term risk, NHC is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
NHC vs MODV Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas MODV's P/E ratio is -0.06. In terms of profitability, NHC's ROE is +0.10%, compared to MODV's ROE of +0.88%. Regarding short-term risk, NHC is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for NHC.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
NHC vs GBNH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas GBNH's P/E ratio is -0.06. In terms of profitability, NHC's ROE is +0.10%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, NHC is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for NHC.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
NHC vs RHE Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas RHE's P/E ratio is -1.79. In terms of profitability, NHC's ROE is +0.10%, compared to RHE's ROE of +1.09%. Regarding short-term risk, NHC is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for NHC.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
NHC vs RHE-PA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, NHC's ROE is +0.10%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, NHC is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
NHC vs TOIIW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, NHC's ROE is +0.10%, compared to TOIIW's ROE of +1.51%. Regarding short-term risk, NHC is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for NHC.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
NHC vs AIDX Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AIDX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AIDX's P/E ratio is -0.27. In terms of profitability, NHC's ROE is +0.10%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, NHC is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
NHC vs IMACW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas IMACW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, NHC is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check IMACW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
NHC vs STLNW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, STLNW has a market cap of 1.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while STLNW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas STLNW's P/E ratio is -0.04. In terms of profitability, NHC's ROE is +0.10%, compared to STLNW's ROE of +1.51%. Regarding short-term risk, NHC is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check STLNW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
NHC vs EDVA Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, EDVA has a market cap of 1.2M. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while EDVA trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas EDVA's P/E ratio is -0.01. In terms of profitability, NHC's ROE is +0.10%, compared to EDVA's ROE of N/A. Regarding short-term risk, NHC is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for NHC.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
NHC vs EUDAW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, EUDAW has a market cap of 616.3K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas EUDAW's P/E ratio is -0.01. In terms of profitability, NHC's ROE is +0.10%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, NHC is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for NHC.Check EUDAW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
NHC vs NIVF Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, NIVF has a market cap of 552.8K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while NIVF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas NIVF's P/E ratio is 0.22. In terms of profitability, NHC's ROE is +0.10%, compared to NIVF's ROE of -292.08%. Regarding short-term risk, NHC is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for NHC.Check NIVF's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
NHC vs CCM Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, CCM has a market cap of 536.9K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while CCM trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas CCM's P/E ratio is -1.25. In terms of profitability, NHC's ROE is +0.10%, compared to CCM's ROE of +0.05%. Regarding short-term risk, NHC is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for NHC.Check CCM's competition here
Talkspace, Inc. (NASDAQ: TALKW)
NHC vs TALKW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TALKW's P/E ratio is 0.00. In terms of profitability, NHC's ROE is +0.10%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, NHC is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
NHC vs MNDR Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, MNDR has a market cap of 23.3K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while MNDR trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas MNDR's P/E ratio is -0.06. In terms of profitability, NHC's ROE is +0.10%, compared to MNDR's ROE of -0.31%. Regarding short-term risk, NHC is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for NHC.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
NHC vs NIVFW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, NIVFW has a market cap of 20.5K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while NIVFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas NIVFW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, NHC is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check NIVFW's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
NHC vs TNONW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TNONW has a market cap of 5.6K. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TNONW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to TNONW's ROE of N/A. Regarding short-term risk, NHC is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check TNONW's competition here
Hanger, Inc. (NYSE: HNGR)
NHC vs HNGR Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas HNGR's P/E ratio is 19.71. In terms of profitability, NHC's ROE is +0.10%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, NHC is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for NHC.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
NHC vs SLHGP Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, NHC's ROE is +0.10%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, NHC is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for NHC.Check SLHGP's competition here
New Frontier Health Corporation (NYSE: NFH)
NHC vs NFH Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, NFH has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas NFH's P/E ratio is -19.75. In terms of profitability, NHC's ROE is +0.10%, compared to NFH's ROE of -0.06%. Regarding short-term risk, NHC is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for NHC.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
NHC vs SLHG Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas SLHG's P/E ratio is -1.48. In terms of profitability, NHC's ROE is +0.10%, compared to SLHG's ROE of N/A. Regarding short-term risk, NHC is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for NHC.Check SLHG's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
NHC vs ATIP-WT Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, NHC is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for NHC.Check ATIP-WT's competition here
Almost Family Inc. (NASDAQ: AFAM)
NHC vs AFAM Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas AFAM's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, NHC is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for NHC.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
NHC vs TLMD Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TLMD's P/E ratio is -1.60. In terms of profitability, NHC's ROE is +0.10%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, NHC is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for NHC.Check TLMD's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
NHC vs DVCR Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas DVCR's P/E ratio is 28.34. In terms of profitability, NHC's ROE is +0.10%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, NHC is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for NHC.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
NHC vs TLMDW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TLMDW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, NHC is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check TLMDW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
NHC vs KND Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, KND has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas KND's P/E ratio is -1.14. In terms of profitability, NHC's ROE is +0.10%, compared to KND's ROE of -0.53%. Regarding short-term risk, NHC is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for NHC.Check KND's competition here
DocGo Inc. (NASDAQ: DCGOW)
NHC vs DCGOW Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas DCGOW's P/E ratio is N/A. In terms of profitability, NHC's ROE is +0.10%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, NHC is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for NHC.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
NHC vs TVTY Comparison November 2026
National HealthCare Corporation (AMEX: NHC) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NHC stands at 3.3B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, NHC is priced at $212.79 on the AMEX, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NHC currently has a P/E ratio of 26.46, whereas TVTY's P/E ratio is 19.06. In terms of profitability, NHC's ROE is +0.10%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, NHC is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for NHC.Check TVTY's competition here